Skeletal remodeling in health and disease

被引:851
作者
Zaidi, Mone [1 ]
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
关键词
D O I
10.1038/nm1593
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of genetically manipulated mouse models, gene and protein discovery and the cataloguing of genetic mutations have each allowed us to obtain new insights into skeletal morphogenesis and remodeling. These techniques have made it possible to identify molecules that are obligatory for specific cellular functions, and to exploit these molecules for therapeutic purposes. New insights into the pathophysiology of diseases have also enabled us to understand molecular defects in a way that was not possible a decade ago. This review summarizes our current understanding of the carefully orchestrated cross-talk between cells of the bone marrow and between bone cells and the brain through which bone is constantly remodeled during adult life. It also highlights molecular aberrations that cause bone cells to become dysfunctional, as well as therapeutic options and opportunities to counteract skeletal loss.
引用
收藏
页码:791 / 801
页数:11
相关论文
共 124 条
  • [1] TSH is a negative regulator of skeletal remodeling
    Abe, E
    Marians, RC
    Yu, WQ
    Wu, XB
    Ando, T
    Li, YN
    Iqbal, J
    Eldeiry, L
    Rajendren, G
    Blair, HC
    Davies, TF
    Zaidi, M
    [J]. CELL, 2003, 115 (02) : 151 - 162
  • [2] Mode of action of interleukin-6 on mature osteoclasts.: Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption
    Adebanjo, OA
    Moonga, BS
    Yamate, T
    Sun, L
    Minkin, C
    Abe, E
    Zaidi, M
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 142 (05) : 1347 - 1356
  • [3] Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim
    Akiyama, T
    Bouillet, P
    Miyazaki, T
    Kadono, Y
    Chikuda, H
    Chung, UG
    Fukuda, A
    Hikita, A
    Seto, H
    Okada, T
    Inaba, T
    Sanjay, A
    Baron, R
    Kawaguchi, H
    Oda, H
    Nakamura, K
    Strasser, A
    Tanaka, S
    [J]. EMBO JOURNAL, 2003, 22 (24) : 6653 - 6664
  • [4] Postmenopausal osteoporosis - Its clinical features
    Albright, F
    Smith, PH
    Richardson, AM
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1941, 116 : 2465 - 2474
  • [5] Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT
    Almeida, M
    Han, L
    Bellido, T
    Manolagas, SC
    Kousteni, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) : 41342 - 41351
  • [6] Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
    Asagiri, M
    Sato, K
    Usami, T
    Ochi, S
    Nishina, H
    Yoshida, H
    Morita, I
    Wagner, EF
    Mak, TW
    Serfling, E
    Takayanagi, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (09) : 1261 - 1269
  • [7] Hypothalamic Y2 receptors regulate bone formation
    Baldock, PA
    Sainsbury, A
    Couzens, M
    Enriquez, RF
    Thomas, GP
    Gardiner, EM
    Herzog, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (07) : 915 - 921
  • [8] Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism
    Bassett, J. H. Duncan
    O'Shea, Patrick J.
    Sriskantharajah, Srividya
    Rabier, Benedicte
    Boyde, Alan
    Howell, Peter G. T.
    Weiss, Roy E.
    Roux, Jean-Paul
    Malaval, Luc
    Clement-Lacroix, Phillipe
    Samarut, Jacques
    Chassande, Olivier
    Williams, Graham R.
    [J]. MOLECULAR ENDOCRINOLOGY, 2007, 21 (05) : 1095 - 1107
  • [9] Use of statins and fracture - Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials
    Bauer, DC
    Mundy, GR
    Jamal, SA
    Black, DM
    Cauley, JA
    Ensrud, KE
    van der Klift, M
    Pols, HAP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) : 146 - 152
  • [10] Risk for fracture in women with low serum levels of thyroid-stimulating hormone
    Bauer, DC
    Ettinger, B
    Nevitt, MC
    Stone, KL
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 561 - 568